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What is it? The Mediator complex 
is an enormous, multi-subunit 
protein complex that regulates 
gene expression in eukaryotic 
cells. It acts as a molecular circuit 
board that integrates physiological 
and developmental signals and 
transmits them to RNA polymerase 
II (Pol II), the enzyme charged with 
transcription of all protein-encoding 
genes. Although initially discovered 
as a cofactor required for activator-
dependent transcription, Mediator 
also stimulates activator-independent 
(basal) transcription. Furthermore, 
Mediator can act as a co-repressor 
that facilitates transcriptional 
silencing. Mediator activity is not 
limited to its effects on transcription 
initiation, but it can also affect 
elongation and perhaps all stages of 
the transcription cycle.
How was Mediator discovered? 
First, a little background information. 
The 12-subunit Pol II complex (Rpb1–
Rpb12) is all that is required for its 
catalytic activity, i.e. DNA template-
directed RNA synthesis. However, 
Pol II is unable to recognize promoter 
DNA on its own and instead requires 
five general transcription factors 
(GTFs) — TFIIB, TFIID, TFIIE, TFIIF 
and TFIIH. The GTFs and Pol II 
assemble in a defined order on 
promoter DNA to form a pre-initiation 
complex (PIC). The PIC is sufficient 
for accurate start-site selection, but 
does not respond to transcriptional 
activators. Indeed, as the GTFs 
were purified to homogeneity, 
the Pol II response to activators 
became increasingly weaker. This 
provided a biochemical assay that 
led to the discovery of Mediator 
as a component of a yeast cell 
extract that dramatically stimulated 
activator-dependent transcription. 
Accordingly, Mediator is a key link in 
the pathway leading from enhancer-
bound activators to promoter-bound 
Pol II.Purification of Mediator revealed 
that several of its subunits had 
been identified previously in genetic 
screens for regulators of gene 
expression in yeast. In fact, a single 
genetic selection for suppressors 
of a growth defect associated with 
truncation of the carboxy-terminal 
domain (CTD) of the Rpb1 subunit 
of Pol II identified nine different 
Mediator components (SRB genes). 
Additional subunits had also been 
identified in other screens for 
mutants that either activated or 
repressed gene expression. Thus, the 
synergy of biochemistry and genetics 
led to the discovery of Mediator 
as an essential regulator of Pol II 
transcription. The identification of 
more than a third of its components 
as the products of SRB genes 
suggested that Mediator affects gene 
expression, at least in part, through 
the Pol II CTD. More on that in a 
moment...
Is Mediator found in organisms 
other than yeast? Mediator appears 
to be a universal requirement for Pol 
II transcription. Several Mediator-
like complexes were identified in 
transcription systems derived from 
fly, worm, mouse, rat and human 
cells. Each complex was named 
according to how it was discovered: 
TRAP (thyroid hormone receptor-
associated proteins), SMCC (SRB/
Mediator co-activator complex), 
ARC (activator-recruited complex), 
DRIP (vitamin D receptor-interacting 
proteins), CRSP (cofactor required 
for Sp1 activation) and PC2 (positive 
cofactor 2). In each case, these 
complexes were required for the 
response to transcriptional regulators 
in vitro. However, their relationship 
to each other and to Mediator was 
not immediately apparent due 
to subunit heterogeneity and to 
amino acid sequence divergence 
among orthologous subunits. 
Further characterization of these 
complexes established that all are 
metazoan counterparts of Mediator 
with a common modular structure 
that includes orthologs of all yeast 
subunits (Figure 1). Metazoan 
Mediator complexes often include 
additional subunits not found 
in yeast Mediator and exist in 
multiple forms with variable subunit 
composition, reflecting more complex 
transcriptional regulatory programs in 
these organisms.Is Mediator required for expression 
of all genes? It seems so. Inactivation 
of the Med17 (SRB4 gene) subunit 
of yeast Mediator has the same 
deleterious effect on transcription as 
inactivation of the Rpb1 subunit of 
Pol II — essentially abolishing mRNA 
synthesis. Furthermore, a technique 
called chromatin immunoprecipitation 
(ChIP), which queries the association 
of specific proteins at any site in 
the genome, detected Mediator at 
the promoters of nearly all genes. 
As mentioned above, Mediator also 
stimulates activator-independent 
transcription. Indeed, in vitro 
transcription is so inefficient in the 
absence of Mediator that Mediator 
might be more appropriately viewed 
as a GTF, essential for all Pol II 
transcription. 
What does Mediator look like? Yeast 
Mediator consists of 25 subunits 
with a molecular mass of ~1 million 
Daltons. Electron microscopy defined 
a modular structure consisting of 
four domains: head, middle/arm, 
tail and kinase (Figure 1). The head 
module can stimulate activator-
independent transcription, but does 
not respond to activators. Conversely, 
the tail module is the direct target 
of specific regulatory proteins 
and appears to be responsible for 
recruitment of Mediator to DNA. The 
middle/arm module is a highly flexible 
structure that orchestrates extensive 
conformational changes upon 
Mediator binding to Pol II. 
The hallmark of the kinase 
module is the Cdk8–cyclin C pair 
(Srb10–Srb11), which assembles 
with Med12 and Med13 (Figure 1). 
All four of these subunits were 
discovered as SRB genes, implicating 
the kinase module in CTD function. 
This interaction might account, in 
part, for the co-repressor function 
of Mediator: Pol II is recruited to the 
promoter in hypo-phosphorylated 
form such that Cdk8-catalyzed CTD 
phosphorylation prevents Pol II 
assembly into the PIC. In human 
cells, a very different function for 
the Cdk8–cyclin C module has been 
reported: epigenetic silencing of 
neuronal genes via covalent histone 
modification. Furthermore, stimulatory 
effects on transcription have also 
been demonstrated for Cdk8 in yeast 
and metazoan cells, underscoring 
the enigmatic nature of the kinase 
module.
Magazine
R1031
Figure 1. The Mediator complex. 
(A) The 25-subunit yeast Mediator complex consists of four structurally distinct modules: head, middle/arm, tail and kinase. Although a uni-
form nomenclature has been assigned to orthologous Mediator subunits from eukaryotic organisms, nine of the yeast subunits were identi-
fied in a genetic selection for suppressors of truncation of the Pol II carboxy-terminal domain (CTD); these genes were designated SRBs, 
including SRB8 to SRB11. (B) A ribbon model of the yeast Mediator head module, composed of 7 subunits, as seen from different angles. 
Med17 (cyan), Med11 (purple), Med22 (yellow), Med6 (green), Med8 (orange), Med18 (blue), and Med20 (red). This image was generously 
provided by Dr. Yuichiro Takagi (Indiana University School of Medicine).What does the structure of Mediator 
reveal about its function? Just as 
high-resolution images of Pol II and 
the ribosome are unraveling the 
mechanisms of transcription and 
protein synthesis, structural studies 
of Mediator are providing insight into 
how this complex machine regulates 
transcription. The architecture of the 
head module was recently solved 
to high resolution, defining three 
structural domains — the neck, fixed 
jaw and movable jaw. These domains 
are built around a bundle of ten 
a-helices derived from five different 
subunits (Figure 1). Structural and 
biochemical information suggests 
that the head module positions the 
Pol II CTD in proximity to TFIIH, 
where the TFIIH kinase (Cdk7) 
stimulates CTD phosphorylation, 
in this case (as opposed to Cdk8; 
see above) promoting dissociation 
of Pol II from Mediator, coinciding 
with the transition from initiation to 
elongation. These structures also 
provide an informative framework for 
interpreting the earlier SRB and other 
MED mutations, including secondary 
mutations that suppress primary 
mutations. For example, a Med17 
defect is suppressed by a Med6 
mutation, apparently by creating a 
stabilizing salt-bridge between the 
two subunits.  
Recent cryo-EM images of the 
head module in association with a minimal, functional PIC have 
also illuminated the mechanism of 
promoter binding. The jaws bind 
the Rpb4–Rpb7 subunits of Pol II, 
along with the ‘clamp’ that closes 
over the active site cleft. In the 
Pol II closed conformation, the cleft 
is large enough to accommodate 
single-stranded DNA, but not double-
stranded DNA. Either the two strands 
of promoter DNA must melt prior to 
PIC assembly, or Pol II must undergo 
a conformational change that opens 
the cleft. The cryo-EM map suggests 
the latter: head interactions with Pol 
II cause repositioning of Rpb4–Rpb7 
and a large rearrangement of the 
clamp, thereby opening the active site 
cleft. This model could account for the 
stimulatory effect of Mediator on basal 
transcription and suggests that clamp 
opening is a fundamental aspect of 
Mediator function. 
Does Mediator play a role in human 
disease? Mediator appears to 
play a role in diverse pathological 
states, including tumorigenesis, 
cardiovascular disease, neurological 
disease, and metabolic disorders. For 
instance, Med19 is upregulated in a 
variety of cancers, such as bladder 
cancer, breast cancer, lung tumors, 
and osteosarcoma. In addition, the 
X-linked Lujan and Opitz-Kaveggia 
mental retardation syndromes are 
caused by mutations in Med12, while mutations in Med13 have been 
found in patients with congenital 
heart defects. The fact that Mediator 
is a core component of the gene 
expression machinery indicates that 
defects in the transcriptional program 
are at the heart of these disorders.
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